![Maryjo Chamberlain-Tharp](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Maryjo Chamberlain-Tharp
Corporate Officer/Principal chez
NEUMORA THERAPEUTICS, INC.
Profil
Maryjo Chamberlain-Tharp currently works at ARCH Venture Partners LLC, as Venture Partner from 2025 and Neumora Therapeutics, Inc., as Chief Business Officer from 2022.
Dr. Chamberlain-Tharp also formerly worked at Eli Lilly & Co., as Head-Neuroscience & East Coast Operations from 1997 to 2014 and AbbVie, Inc., as Global Head-Academic Outreach from 2014 to 2021.
Dr. Chamberlain-Tharp received his doctorate degree from Walden University LLC, undergraduate degree from Purdue University, and Masters Business Admin degree from Indiana University Bloomington.
Postes actifs de Maryjo Chamberlain-Tharp
| Sociétés | Poste | Début |
|---|---|---|
| NEUMORA THERAPEUTICS, INC. | Corporate Officer/Principal | 01/08/2021 |
ARCH Venture Partners LLC
 ARCH Venture Partners LLC Investment ManagersFinance ARCH Venture Partners invests in disruptive science companies located in the United States. The firm target companies operating in the fields of biotechnology and technology sectors. It provides financing for early stage capital requirements with a minimum investment size of $0.05 million and also makes co-investments. | Private Equity Investor | 01/07/2025 |
Anciens postes connus de Maryjo Chamberlain-Tharp
| Sociétés | Poste | Fin |
|---|---|---|
| ABBVIE INC. | Corporate Officer/Principal | 01/08/2021 |
| ELI LILLY AND COMPANY | Corporate Officer/Principal | 01/01/2014 |
Formation de Maryjo Chamberlain-Tharp
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
76
Relations au 1er degré
7
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 7 |
|---|---|
Eli Lilly & Co.
 Eli Lilly & Co. Pharmaceuticals: MajorHealth Technology Manufactures, wholesales and markets pharmaceutical products | Health Technology |
ARCH Venture Partners LLC
ARCH Venture Partners LLC Investment ManagersFinance ARCH Venture Partners invests in disruptive science companies located in the United States. The firm target companies operating in the fields of biotechnology and technology sectors. It provides financing for early stage capital requirements with a minimum investment size of $0.05 million and also makes co-investments. | Finance |
AbbVie, Inc.
 AbbVie, Inc. Pharmaceuticals: MajorHealth Technology Engages in the research and development, manufacturing, commercialization & sale of immunology medicines and therapies | Health Technology |
Walden University LLC
 Walden University LLC Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Purdue University
 Purdue University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Neumora Therapeutics, Inc.
 Neumora Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company which develops medicines for brain diseases | Health Technology |
Indiana University Bloomington
 Indiana University Bloomington Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
